_id
69109a2accc777a4e85d5cbf
Ticker
EWTX
Name
Edgewise Therapeutics Inc
Exchange
NASDAQ
Address
1715 38th Street, Boulder, CO, United States, 80301
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://edgewisetx.com
Description
Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, EDG-5506, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders that is in Phase I clinical trials. In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. The company was incorporated in 2017 and is headquartered in Boulder, Colorado.
Last Close
23.43
Volume
365167
Current Price
23.62
Change
0.8109261630388446
Last Updated
2025-11-30T18:27:55.222Z
Image
data:image/webp;base64,UklGRrYIAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSM4FAAABuTJE9D9MVtz/d1vbuq/33nvvD1f45v1gp72/d1/vvVdgJ9nOK/g3gaWwLQ/hscjswMOisD0EK2xrTWApLPIQwqKwMwQH7hlYYdYawV9hkWdwWBR26GVW2J2BFZg1hM0iswsPtML2DKywMwQrLPIMDtvKEA6LwvYMosAoYgIm4LH4H/Tp8E8n9TRclMEzPMsLPce//M0fhVQaf57nezb+F3/wV/9gUPBmb/MyG/lnP/S4nwhLea7XeIs3ioX9a9/yHbYh5ovdbY9NGf3cj/3IjIrjq9XrvYop2O+d3fzG3xnxaiuL/06G+BV2v7J2VTHsBVYv91sJUXenbN83YrXiDMD4DVZRLRLE9YjLZ9o5LqDi6Yuo2bkRu7ENrbV8ndcyBYqU0dqFVu2ccGtErjwdqGnfpGJ49jO2DignYcT2T8aWhnW+5wc8WYxwLtsvoTR7N4aRv1CNlxZAw/l3+VlxefNNXqnBgbRq1w0ZrjteZSc78+00hwAVIGz9nxo3Xkps13J3MKRzOku6E7Z3qYcSs2+64Vacd2qLLk442PAszeCuj3OXrMpOloKkepylsA4HALmlxN4uzrR2lszcqi3ms3WVS47SRe34fVtSAGQw6eYiTMKoiOCt3q4e5Cw5/bYjwBhOmIgRAFw+6u/yzB7du7ELyN2j+xtI8rYXZy4M77bbO4cTpTdXidDrLRcqAsbTg8z2QkgjhJRxLubAplGncDjXm/RUBgDL5iIQHgx2pFcDAGcQi18a6jkO9MeHnoLh2Qi6eTdPQz0ilnNNFmwU52QEJ2JhlmtI5CA9N3Q2jmZ09sCTxI0gLoKH7brGS8IF9JOE5Q2HU2d+vs4kDBb5anDocYqGIasXGM0vWr1GEF6HTQeAMESw+YVvLS2vNWr0ULhz70KNkYWoowy9r7kDK4ebVbhesLCC2dW9I7P6XV4OSDrrVqgGt29X7HBrK3WY1M3t8cu+IUW5Uuivo/z/7zfYRaPq/INUf0qeSf7ZA1YuWn55fyAjh7dOP0YuukRWnFb9p8rpnSoHiyhw3NrHiRYANFYNZLZTLl7g0BAAlqv+h2SJBoPLjYQoFwmyRxo0Kz2KdKxN7HAqF07RPtPZOAk3Y82e5SZH2VKUqVizjz5HDZqa45OJB1kuAuai/VDj+5+g+s0JMPdne4GoXBDxuDk4EKqz1ieJmhs46X4zkSjnr1tfh4Hl2d3x54lWC07EmybKmh7cnJPpoeGIbH6dROPKe9zeZMPTlMqBb6aNfH/nK9Y1cxcD2G9Dr3//UVOl81ZnWw67Xn+5YedXjztF4cU73Kc9l4G49VRknPMuT0hbUICbW2GBcePuNCVYdcc/mzMhjRAyP7SbNsFZjmcXrVCvXlcMAJ8cmlPFOBkBKHY6BMCthkPVud7CigjaXvvSJBgsvWMGrbUIko4elxK6eZQyIm5QHuc6XAkBfc9DnGtq1wmD0ZTXD5YmC0VcoNphTtMEqn5iK9Moj8X1Zg+Ijp6aFOhc17J6f1M7vc4UAGGIyPZCHabdtJXIriwgkqubFIKbizbKcHt2UYtIYnM/QGH75k5iZ/nCkgCUIkZ0Epwrzhjw5FWrxlRQN1GsFyYhKRPAZFXp0fZ47opSpHU5WMjObF0V+06NyQCl2qkAAGvVPCwoXJ9Xt6UsJs2KxWvz83WIKM1w0r1+s1fr5JsNXd0SxcknHvE0zXrjZD2rwsBGZRIA6B2s9bGjiOsRZ73LSkhAfRWNZmsjDpM9APBG42ElFyhSZrMjA4BuLxjNjVhYNQ3kpH1psmKUd9yTBpaVukYIkevwbDjMeDGUNw6mDs84jNy6QV0CCDv+aXHC7Dd7XQBi5FmG+GvercTK9U+VZapiWOZm08GY2bMaWxmynqV8t8D+elvnYKAChFqrs1vGqG2ZYxoSJTdnLmP5sjJGieT7/jxTsns3gLH7i6vqXgQWR8muf+HvZWzlMJp5NQ8nS6nrEcozOyEA4kQAVlA4IMICAAAwDgCdASpAAEAAPrVKnUq/pCKhrhkri/AWiWxrodCZA0q5/AKGrb8rsx/BKj87vcT9RW2Y8zH7Xeun0SXUb7y5/fyxYtsT1VFqjxfSOX72YG1OIoDf62DDZVLLMkiiQeqWX0bbdlp/jT57yAZnYkn6PPGcBek5yNPtgAD++Q3+ee/n9fOAle5Wp/q6oikCFHs6+cQAWs3/EGK8LyD6zlmQT8241/t/egLEn6XmBpDLGLSsnxKqz6q4tHSyB/JbgJ8UyxzEUCZN9HsKNWQg6pRfknDkkMR28zb7Wqm0dzsV9Skd6k0LTfzpfwL//nQf/DCf0el2R5FOXuFn5rfKYbxL8H14/BqCT6S3YxED40bPJaUgCLLJE1LEQABkIRIY0CXxLEq7Pp9TqZbuW7xSj5bHmvigjavK70C3YQbSdWzL/iD+JZ5/8HFYeVBqsUtoCH/85G/DyuDV/4pKzlAPyabu0OXQ4Eb9KiGwNZZNE8XnsHlenjjmxA7oJFObFeV6DgNXdnsplgMIoT0XoCgyP/j9J171vr+4S81B108gk8ZIk1nN9j5h0xMvFQp3VJpZZ4CpNPe/w3IFJpUYGUeUgcE9dOmIzLoeKRCUqMnNTSKTkXb8mLSMX9rw4WelCDBxWNP10Loc+ELeBU7jwwtEIDw/RJRgXo8QDlzzFDNsEAWJe6LxpFsjGhCxPMA0c7Obnv1ulOQzgk5i7c5tR/jAOkw9ITXsX9f/k33H9W79v1Keoh/ZXDqHh6C0j6R949l+X2gUnDsGzUqDTkeGsa+0Edpau5q3Ceod7YmF2F2j3Zxl6w8eEFOVqWvENhVHpDlKGZvu45O9t3TahWBJovknEAxRL8w8np01opo0/UcaUZfmY6OrW3yj7MZYlw/EHl8bFaDV+InLc0Qh4NTIyFoftTph8LHAmXxOfOnI/j9pklN6MAAA
Ipo Date
2021-03-26T00:00:00.000Z
Market Cap
2756814080
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.8147625000000001
Sentiment Sources
16
Rating
4.3
Target Price
38.1667
Strong Buy
5
Buy
3
Hold
2
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
46858000
Operating Income
-46858000
Interest Expense
-
Pretax Income
-40666000
Net Income
-40666000
Eps
-0.3854861004277838
Dividends Per Share
-
Shares Outstanding
105868434
Income Tax Expense
-
EBITDA
-40143000
Operating Margin
-
Total Other Income Expense Net
6192000
Cash
46003000
Short Term Investments
517337000
Receivables
-
Inventories
-
Total Current Assets
573900000
Property Plant Equipment
9566000
Total Assets
583466000
Payables
6157000
Short Term Debt
1008000
Long Term Debt
-
Total Liabilities
24819000
Equity
558647000
Depreciation
570000
Change In Working Capital
1423000
Cash From Operations
-34776000
Capital Expenditures
89000
Cash From Investing
35716000
Cash From Financing
1659000
Net Change In Cash
2599000
PE
-
PB
4.460311144568932
ROE
-7.279373199891882
ROA
-6.969729170165871
FCF
-34865000
Fcf Percent
-
Piotroski FScore
1
Health Score
38
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
46858000
Quarters > 0 > income Statement > operating Income
-46858000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-40666000
Quarters > 0 > income Statement > net Income
-40666000
Quarters > 0 > income Statement > eps
-0.3854861004277838
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
105492779
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-40143000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
6192000
Quarters > 0 > balance Sheet > cash
46003000
Quarters > 0 > balance Sheet > short Term Investments
517337000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
573900000
Quarters > 0 > balance Sheet > property Plant Equipment
9566000
Quarters > 0 > balance Sheet > total Assets
583466000
Quarters > 0 > balance Sheet > payables
6157000
Quarters > 0 > balance Sheet > short Term Debt
1008000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
24819000
Quarters > 0 > balance Sheet > equity
558647000
Quarters > 0 > cash Flow > net Income
-40666000
Quarters > 0 > cash Flow > depreciation
570000
Quarters > 0 > cash Flow > change In Working Capital
1423000
Quarters > 0 > cash Flow > cash From Operations
-34776000
Quarters > 0 > cash Flow > capital Expenditures
89000
Quarters > 0 > cash Flow > cash From Investing
35716000
Quarters > 0 > cash Flow > cash From Financing
1659000
Quarters > 0 > cash Flow > net Change In Cash
2599000
Quarters > 0 > ratios > PE
-0.3854861004277838
Quarters > 0 > ratios > PB
4.460311144568932
Quarters > 0 > ratios > ROE
-7.279373199891882
Quarters > 0 > ratios > ROA
-6.969729170165871
Quarters > 0 > ratios > FCF
-34865000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
567000
Quarters > 1 > income Statement > gross Profit
-567000
Quarters > 1 > income Statement > operating Expenses
42610000
Quarters > 1 > income Statement > operating Income
-42610000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-36115000
Quarters > 1 > income Statement > net Income
-36115000
Quarters > 1 > income Statement > eps
-0.3441474207673105
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
104940493
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-42043000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
6495000
Quarters > 1 > balance Sheet > cash
43404000
Quarters > 1 > balance Sheet > short Term Investments
550588000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
603255000
Quarters > 1 > balance Sheet > property Plant Equipment
10079000
Quarters > 1 > balance Sheet > total Assets
613334000
Quarters > 1 > balance Sheet > payables
8320000
Quarters > 1 > balance Sheet > short Term Debt
1004000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
24263000
Quarters > 1 > balance Sheet > equity
589071000
Quarters > 1 > cash Flow > net Income
-36115000
Quarters > 1 > cash Flow > depreciation
567000
Quarters > 1 > cash Flow > change In Working Capital
-2564000
Quarters > 1 > cash Flow > cash From Operations
-32582000
Quarters > 1 > cash Flow > capital Expenditures
50000
Quarters > 1 > cash Flow > cash From Investing
-162166000
Quarters > 1 > cash Flow > cash From Financing
188231000
Quarters > 1 > cash Flow > net Change In Cash
-6517000
Quarters > 1 > ratios > PE
-0.3441474207673105
Quarters > 1 > ratios > PB
4.207802530866398
Quarters > 1 > ratios > ROE
-6.13083991573172
Quarters > 1 > ratios > ROA
-5.888308817055633
Quarters > 1 > ratios > FCF
-32632000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
38
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
554000
Quarters > 2 > income Statement > gross Profit
-554000
Quarters > 2 > income Statement > operating Expenses
45959000
Quarters > 2 > income Statement > operating Income
-45959000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-40798000
Quarters > 2 > income Statement > net Income
-40798000
Quarters > 2 > income Statement > eps
-0.4288655237057421
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
95130053
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-45405000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
5161000
Quarters > 2 > balance Sheet > cash
49921000
Quarters > 2 > balance Sheet > short Term Investments
386466000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
443178000
Quarters > 2 > balance Sheet > property Plant Equipment
10518000
Quarters > 2 > balance Sheet > total Assets
454391000
Quarters > 2 > balance Sheet > payables
8789000
Quarters > 2 > balance Sheet > short Term Debt
1001000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
24672000
Quarters > 2 > balance Sheet > equity
429719000
Quarters > 2 > cash Flow > net Income
-40798000
Quarters > 2 > cash Flow > depreciation
554000
Quarters > 2 > cash Flow > change In Working Capital
-4758000
Quarters > 2 > cash Flow > cash From Operations
-37866000
Quarters > 2 > cash Flow > capital Expenditures
44000
Quarters > 2 > cash Flow > cash From Investing
43898000
Quarters > 2 > cash Flow > cash From Financing
2223000
Quarters > 2 > cash Flow > net Change In Cash
8255000
Quarters > 2 > ratios > PE
-0.4288655237057421
Quarters > 2 > ratios > PB
5.228932981459978
Quarters > 2 > ratios > ROE
-9.494111268061221
Quarters > 2 > ratios > ROA
-8.978610931994693
Quarters > 2 > ratios > FCF
-37910000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
2118000
Quarters > 3 > income Statement > cost Of Revenue
1059000
Quarters > 3 > income Statement > gross Profit
1059000
Quarters > 3 > income Statement > operating Expenses
45540000
Quarters > 3 > income Statement > operating Income
-45540000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-39662000
Quarters > 3 > income Statement > net Income
-39662000
Quarters > 3 > income Statement > eps
-0.4291744901937925
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
92414626
Quarters > 3 > income Statement > income Tax Expense
-481724
Quarters > 3 > income Statement > EBITDA
-44911000
Quarters > 3 > income Statement > operating Margin
-2150.14164305949
Quarters > 3 > income Statement > total Other Income Expense Net
5878000
Quarters > 3 > balance Sheet > cash
41666000
Quarters > 3 > balance Sheet > short Term Investments
428504000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
475483000
Quarters > 3 > balance Sheet > property Plant Equipment
11072000
Quarters > 3 > balance Sheet > total Assets
486817000
Quarters > 3 > balance Sheet > payables
5579000
Quarters > 3 > balance Sheet > short Term Debt
996000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
27601000
Quarters > 3 > balance Sheet > equity
459216000
Quarters > 3 > cash Flow > net Income
-39662000
Quarters > 3 > cash Flow > depreciation
629000
Quarters > 3 > cash Flow > change In Working Capital
6941000
Quarters > 3 > cash Flow > cash From Operations
-26957000
Quarters > 3 > cash Flow > capital Expenditures
274000
Quarters > 3 > cash Flow > cash From Investing
20922000
Quarters > 3 > cash Flow > cash From Financing
2895000
Quarters > 3 > cash Flow > net Change In Cash
-3140000
Quarters > 3 > ratios > PE
-0.4291744901937925
Quarters > 3 > ratios > PB
4.753391576338804
Quarters > 3 > ratios > ROE
-8.636894184871608
Quarters > 3 > ratios > ROA
-8.147209320956335
Quarters > 3 > ratios > FCF
-27231000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-12.856940509915015
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
2290000
Annuals > 0 > income Statement > gross Profit
-2290000
Annuals > 0 > income Statement > operating Expenses
158832000
Annuals > 0 > income Statement > operating Income
-158832000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-133813000
Annuals > 0 > income Statement > net Income
-133813000
Annuals > 0 > income Statement > eps
-1.4479634424966454
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
92414626
Annuals > 0 > income Statement > income Tax Expense
-1
Annuals > 0 > income Statement > EBITDA
-156542000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
25019000
Annuals > 0 > balance Sheet > cash
41666000
Annuals > 0 > balance Sheet > short Term Investments
428504000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
475483000
Annuals > 0 > balance Sheet > property Plant Equipment
11072000
Annuals > 0 > balance Sheet > total Assets
486817000
Annuals > 0 > balance Sheet > payables
5579000
Annuals > 0 > balance Sheet > short Term Debt
996000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
27601000
Annuals > 0 > balance Sheet > equity
459216000
Annuals > 0 > cash Flow > net Income
-133813000
Annuals > 0 > cash Flow > depreciation
2290000
Annuals > 0 > cash Flow > change In Working Capital
10328000
Annuals > 0 > cash Flow > cash From Operations
-109028000
Annuals > 0 > cash Flow > capital Expenditures
1312000
Annuals > 0 > cash Flow > cash From Investing
-184656000
Annuals > 0 > cash Flow > cash From Financing
249253000
Annuals > 0 > cash Flow > net Change In Cash
-44431000
Annuals > 0 > ratios > PE
-1.4479634424966454
Annuals > 0 > ratios > PB
5.240402906344727
Annuals > 0 > ratios > ROE
-29.13944636075398
Annuals > 0 > ratios > ROA
-27.487330968310474
Annuals > 0 > ratios > FCF
-110340000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
1732000
Annuals > 1 > income Statement > gross Profit
-1732000
Annuals > 1 > income Statement > operating Expenses
114357000
Annuals > 1 > income Statement > operating Income
-114357000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-100163000
Annuals > 1 > income Statement > net Income
-100163000
Annuals > 1 > income Statement > eps
-1.5718352384359955
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
63723600
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-112625000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
14194000
Annuals > 1 > balance Sheet > cash
86097000
Annuals > 1 > balance Sheet > short Term Investments
232296000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
326997000
Annuals > 1 > balance Sheet > property Plant Equipment
12690000
Annuals > 1 > balance Sheet > total Assets
340035000
Annuals > 1 > balance Sheet > payables
4025000
Annuals > 1 > balance Sheet > short Term Debt
980000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
21205000
Annuals > 1 > balance Sheet > equity
318830000
Annuals > 1 > cash Flow > net Income
-100163000
Annuals > 1 > cash Flow > depreciation
1732000
Annuals > 1 > cash Flow > change In Working Capital
-1560000
Annuals > 1 > cash Flow > cash From Operations
-91948000
Annuals > 1 > cash Flow > capital Expenditures
5745000
Annuals > 1 > cash Flow > cash From Investing
102886000
Annuals > 1 > cash Flow > cash From Financing
53166000
Annuals > 1 > cash Flow > net Change In Cash
64104000
Annuals > 1 > ratios > PE
-1.5718352384359955
Annuals > 1 > ratios > PB
5.204537038547188
Annuals > 1 > ratios > ROE
-31.415801524323307
Annuals > 1 > ratios > ROA
-29.45667357771994
Annuals > 1 > ratios > FCF
-97693000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
538000
Annuals > 2 > income Statement > gross Profit
-538000
Annuals > 2 > income Statement > operating Expenses
22079000
Annuals > 2 > income Statement > operating Income
-22079000
Annuals > 2 > income Statement > interest Expense
4018000
Annuals > 2 > income Statement > pretax Income
-19415000
Annuals > 2 > income Statement > net Income
-15397000
Annuals > 2 > income Statement > eps
-0.2872909460175331
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
53593753
Annuals > 2 > income Statement > income Tax Expense
-4018000
Annuals > 2 > income Statement > EBITDA
-21541000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
2664000
Annuals > 2 > balance Sheet > cash
21993000
Annuals > 2 > balance Sheet > short Term Investments
329954000
Annuals > 2 > balance Sheet > receivables
251000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
356999000
Annuals > 2 > balance Sheet > property Plant Equipment
9851000
Annuals > 2 > balance Sheet > total Assets
367101000
Annuals > 2 > balance Sheet > payables
6105000
Annuals > 2 > balance Sheet > short Term Debt
608000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
20385000
Annuals > 2 > balance Sheet > equity
346716000
Annuals > 2 > cash Flow > net Income
-67640000
Annuals > 2 > cash Flow > depreciation
538000
Annuals > 2 > cash Flow > change In Working Capital
4086000
Annuals > 2 > cash Flow > cash From Operations
-52635000
Annuals > 2 > cash Flow > capital Expenditures
5546000
Annuals > 2 > cash Flow > cash From Investing
-70577000
Annuals > 2 > cash Flow > cash From Financing
129639000
Annuals > 2 > cash Flow > net Change In Cash
6427000
Annuals > 2 > ratios > PE
-0.2872909460175331
Annuals > 2 > ratios > PB
4.025142560827882
Annuals > 2 > ratios > ROE
-4.440810346219961
Annuals > 2 > ratios > ROA
-4.194213581548402
Annuals > 2 > ratios > FCF
-58181000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
272000
Annuals > 3 > income Statement > gross Profit
-272000
Annuals > 3 > income Statement > operating Expenses
43215000
Annuals > 3 > income Statement > operating Income
-43215000
Annuals > 3 > income Statement > interest Expense
272000
Annuals > 3 > income Statement > pretax Income
-42813000
Annuals > 3 > income Statement > net Income
-42139000
Annuals > 3 > income Statement > eps
-0.8512876323921055
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
49500308
Annuals > 3 > income Statement > income Tax Expense
-674000
Annuals > 3 > income Statement > EBITDA
-42943000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
402000
Annuals > 3 > balance Sheet > cash
15566000
Annuals > 3 > balance Sheet > short Term Investments
265223000
Annuals > 3 > balance Sheet > receivables
548000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
283773000
Annuals > 3 > balance Sheet > property Plant Equipment
912000
Annuals > 3 > balance Sheet > total Assets
285233000
Annuals > 3 > balance Sheet > payables
3843000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
10850000
Annuals > 3 > balance Sheet > equity
274383000
Annuals > 3 > cash Flow > net Income
-42813000
Annuals > 3 > cash Flow > depreciation
272000
Annuals > 3 > cash Flow > change In Working Capital
4630000
Annuals > 3 > cash Flow > cash From Operations
-33507000
Annuals > 3 > cash Flow > capital Expenditures
668000
Annuals > 3 > cash Flow > cash From Investing
-242227000
Annuals > 3 > cash Flow > cash From Financing
186384000
Annuals > 3 > cash Flow > net Change In Cash
-89350000
Annuals > 3 > ratios > PE
-0.8512876323921055
Annuals > 3 > ratios > PB
4.697769250718886
Annuals > 3 > ratios > ROE
-15.357729888513502
Annuals > 3 > ratios > ROA
-14.773536021428097
Annuals > 3 > ratios > FCF
-34175000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
29
Valuation > metrics > PE
-0.3854861004277838
Valuation > metrics > PB
4.460311144568932
Valuation > final Score
35.39688855431068
Valuation > verdict
48.7% Overvalued
Profitability > metrics > ROE
-7.279373199891882
Profitability > metrics > ROA
-7.085903467503049
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.04442698161808799
Risk > metrics > Interest Coverage
-89.59464627151051
Risk > final Score
-298
Risk > verdict
High
Liquidity > metrics > Current Ratio
80.0976971388695
Liquidity > metrics > Quick Ratio
80.0976971388695
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
37.92197469133602
Prev Valuations > 1
27.71067018540022
Prev Valuations > 2
32.46608423661196
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
31
Prev Risks > 1
20
Prev Risks > 2
25
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:27:27.703Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-06
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.39
Earnings History > 0 > eps Estimate
-0.4009
Earnings History > 0 > eps Difference
0.0109
Earnings History > 0 > surprise Percent
2.7189
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-07
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.34
Earnings History > 1 > eps Estimate
-0.42
Earnings History > 1 > eps Difference
0.08
Earnings History > 1 > surprise Percent
19.0476
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-07
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.43
Earnings History > 2 > eps Estimate
-0.4211
Earnings History > 2 > eps Difference
-0.0089
Earnings History > 2 > surprise Percent
-2.1135
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-20
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.42
Earnings History > 3 > eps Estimate
-0.4222
Earnings History > 3 > eps Difference
0.0022
Earnings History > 3 > surprise Percent
0.5211
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-07
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.36
Earnings History > 4 > eps Estimate
-0.37
Earnings History > 4 > eps Difference
0.01
Earnings History > 4 > surprise Percent
2.7027
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.34
Earnings History > 5 > eps Estimate
-0.34
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
0
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.33
Earnings History > 6 > eps Estimate
-0.39
Earnings History > 6 > eps Difference
0.06
Earnings History > 6 > surprise Percent
15.3846
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-22
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.47
Earnings History > 7 > eps Estimate
-0.43
Earnings History > 7 > eps Difference
-0.04
Earnings History > 7 > surprise Percent
-9.3023
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-09
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.41
Earnings History > 8 > eps Estimate
-0.4
Earnings History > 8 > eps Difference
-0.01
Earnings History > 8 > surprise Percent
-2.5
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.34
Earnings History > 9 > eps Estimate
-0.4
Earnings History > 9 > eps Difference
0.06
Earnings History > 9 > surprise Percent
15
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.36
Earnings History > 10 > eps Estimate
-0.36
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
0
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-02-23
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.31
Earnings History > 11 > eps Estimate
-0.34
Earnings History > 11 > eps Difference
0.03
Earnings History > 11 > surprise Percent
8.8235
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-03
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.34
Earnings History > 12 > eps Estimate
-0.36
Earnings History > 12 > eps Difference
0.02
Earnings History > 12 > surprise Percent
5.5556
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-04
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.32
Earnings History > 13 > eps Estimate
-0.32
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
0
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-11
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.3
Earnings History > 14 > eps Estimate
-0.28
Earnings History > 14 > eps Difference
-0.02
Earnings History > 14 > surprise Percent
-7.1429
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-02-24
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.26
Earnings History > 15 > eps Estimate
-0.25
Earnings History > 15 > eps Difference
-0.01
Earnings History > 15 > surprise Percent
-4
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.26
Earnings History > 16 > eps Estimate
-0.22
Earnings History > 16 > eps Difference
-0.04
Earnings History > 16 > surprise Percent
-18.1818
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-09
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.21
Earnings History > 17 > eps Estimate
-0.18
Earnings History > 17 > eps Difference
-0.03
Earnings History > 17 > surprise Percent
-16.6667
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-13
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-4.37
Earnings History > 18 > eps Estimate
-0.16
Earnings History > 18 > eps Difference
-4.21
Earnings History > 18 > surprise Percent
-2631.25
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-26
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
0
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, EDG-5506, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders that is in Phase I clinical trials. In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. The company was incorporated in 2017 and is headquartered in Boulder, Colorado.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AEdgewise Therapeutics (NASDAQ:EWTX) Trading 4% Higher - Still a Buy? MarketBeat
Read more →Braidwell LP Raises Position in Edgewise Therapeutics, Inc. $EWTX MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$38.1667
Analyst Picks
Strong Buy
5
Buy
3
Hold
2
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 105.73% of the total shares of Edgewise Therapeutics Inc
1.
Orbimed Advisors, LLC(14.731%)
since
2025/06/30
2.
RA Capital Management, LLC(9.4001%)
since
2025/06/30
3.
Baker Bros Advisors LP(6.9352%)
since
2025/06/30
4.
BlackRock Inc(6.4369%)
since
2025/06/30
5.
Paradigm Biocapital Advisors LP(5.8307%)
since
2025/06/30
6.
HHG PLC(5.2241%)
since
2025/06/30
7.
Novo A/S(5.0785%)
since
2025/06/30
8.
BRAIDWELL LP(4.9464%)
since
2025/06/30
9.
Vanguard Group Inc(4.5958%)
since
2025/06/30
10.
Perceptive Advisors LLC(4.4045%)
since
2025/06/30
11.
Cormorant Asset Management, LLC(4.0362%)
since
2025/06/30
12.
Siren, L.L.C.(2.9999%)
since
2025/06/30
13.
Vanguard Total Stock Mkt Idx Inv(2.6801%)
since
2025/07/31
14.
Bellevue Group AG(2.6351%)
since
2025/06/30
15.
Driehaus Capital Management LLC(1.9951%)
since
2025/06/30
16.
Deerfield Management Co(1.9624%)
since
2025/06/30
17.
Geode Capital Management, LLC(1.706%)
since
2025/06/30
18.
State Street Corp(1.6911%)
since
2025/06/30
19.
iShares Russell 2000 ETF(1.6742%)
since
2025/08/31
20.
MPM Oncology Impact Management LP(1.6334%)
since
2025/06/30
21.
First Light Asset Management, LLC(1.627%)
since
2025/06/30
22.
BB Biotech AG Ord(1.3564%)
since
2024/12/31
23.
Artisan Partners Limited Partnership(1.3091%)
since
2025/06/30
24.
Polar Capital Biotech S Inc(0.9255%)
since
2025/07/31
25.
Artisan Non-U.S. Small-Mid Growth Comp(0.8678%)
since
2025/06/30
26.
Artisan International Small-Mid Investor(0.8678%)
since
2025/06/30
27.
Janus Henderson Global Life Sciences(0.7956%)
since
2025/06/30
28.
Janus Henderson Global Life Sciences D(0.7956%)
since
2025/06/30
29.
Vanguard Institutional Extnd Mkt Idx Tr(0.7117%)
since
2025/07/31
30.
Fidelity Small Cap Index(0.695%)
since
2025/06/30
31.
Janus Global Life Science AUSD(0.6553%)
since
2025/06/30
32.
Janus Henderson Glb Life Scn I2 USD(0.649%)
since
2025/07/31
33.
iShares Russell 2000 Growth ETF(0.6143%)
since
2025/08/31
34.
American Century Small Cap Growth Inv(0.5786%)
since
2025/06/30
35.
American Century U.S. Small Cap Growth(0.5786%)
since
2025/06/30
36.
Eventide Healthcare & Life Sciences I(0.5395%)
since
2025/06/30
37.
iShares Biotechnology ETF(0.436%)
since
2025/08/31
38.
Victory Pioneer Select Mid Cap Growth A(0.3908%)
since
2025/07/31
39.
Janus Henderson Triton D(0.3712%)
since
2025/06/30
40.
Janus Henderson US SMID Cap Growth(0.3712%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.39
EPS Estimate
-0.4009
EPS Difference
0.0109
Surprise Percent
2.7189%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.